US Stock MarketDetailed Quotes
NAVB Navidea Biopharmaceuticals
Watchlist
0.054
-0.005-9.08% Close 11/28 16:00 ET
0.060High0.054Low34.47KVolume
0.060Open0.060Pre Close2.01KTurnover0.05%Turnover RatioLossP/E (TTM)5.41MMarket Cap0.35052wk HighLossP/E (Static)100.08MShares0.02152wk Low-1.64P/B3.67MFloat Cap365.000Historical High--Dividend TTM67.83MShs Float0.021Historical Low--Div YieldTTM9.08%Amplitude0.058Avg Price1Lot Size
Navidea Biopharmaceuticals Key Stats
EPS
According to the latest financial report of Navidea Biopharmaceuticals, the latest earnings per share (TTM) for the company is -0.02. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Navidea Biopharmaceuticals's free cash flow? The latest report shows it as -10.27M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Navidea Biopharmaceuticals shows that the company's current ratio is 0.56, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Navidea Biopharmaceuticals, the quick ratio is 0.49, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of Navidea Biopharmaceuticals? The latest ROE figure is -221.61%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Navidea Biopharmaceuticals, the total asset return on investment (ROA) is -32.41%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Navidea Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at -8.10K%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Navidea Biopharmaceuticals, the net profit margin is -570.92K%, which is a good sign for its profitability.
Quarterly
Loading...
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--